The role of dietary coconut for the prevention and treatment of Alzheimer's disease: Potential mechanisms of action

British Journal of Nutrition

Volumn 114, Issue 1, 2015, Pages 1-14

  Fernando, W M A D B ^a,b   Martins, Ian J ^a,b   Goozee, K G ^a,b,c,d   Brennan, Charles S ^e   Jayasena, V ^f   Martins, R N ^a,b,c,d  

^a EDITH COWAN UNIVERSITY   (Australia)

^b McCusker Foundation for Alzheimer's Disease Research Inc   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d ARV   (Australia)

^e LINCOLN UNIVERSITY   (New Zealand)

^f CURTIN UNIVERSITY   (Australia)

Author keywords

Alzheimer's; Amyloid; Coconut; Diabetes; Saturated fat

Indexed keywords

ANTIOXIDANT; COCONUT OIL; KETONE BODY; LONG CHAIN FATTY ACID; MEDIUM CHAIN FATTY ACID; AMYLOID BETA PROTEIN; FAT INTAKE; FATTY ACID; LOW DENSITY LIPOPROTEIN; VEGETABLE OIL;

ADVERSE OUTCOME; ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; CHOLESTEROL METABOLISM; COCONUT MILK; DRUG MECHANISM; FATTY ACID METABOLISM; HUMAN; INSULIN RESISTANCE; KETOGENIC DIET; LIPID BLOOD LEVEL; LIPID COMPOSITION; LIPOPROTEIN METABOLISM; NEUROPROTECTION; NONHUMAN; REVIEW; STRUCTURE ANALYSIS; ADMINISTRATION AND DOSAGE; ANTAGONISTS AND INHIBITORS; AUSTRALIA; BLOOD; BRAIN; CHEMISTRY; COCONUT; DIET; DIET SUPPLEMENTATION; DIETARY FIBER; FAT INTAKE; FRUIT; FUNCTIONAL FOOD; HYPERLIPIDEMIAS; HYPERTENSION; INTESTINE ABSORPTION; METABOLISM; NUTRITIONAL VALUE; OBESITY; RISK FACTOR; STRUCTURE ACTIVITY RELATION;

COCOS NUCIFERA;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANTIOXIDANTS; AUSTRALIA; BRAIN; COCOS; DIET; DIETARY FATS; DIETARY FIBER; DIETARY SUPPLEMENTS; FATTY ACIDS; FRUIT; FUNCTIONAL FOOD; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; INSULIN RESISTANCE; INTESTINAL ABSORPTION; KETONE BODIES; LIPOPROTEINS, LDL; NUTRITIVE VALUE; OBESITY; PLANT OILS; RISK FACTORS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84937643181     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114515001452     Document Type: Review

References (176)

1. Chetelat G, Villemagne VL, Bourgeat P, et al. (2010) Relationship between atrophy and β-amyloid deposition in Alzheimer disease. Ann Neurol 67, 317-324.
2. Villain N, Chetelat G, Grassiot B, et al. (2012) Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study. Brain Res Bull 135, 2126-2139.
3. Marina AM, Che Man YB & Nazimah AH (2009) Chemical properties of virgin coconut oil. J Am Oil Chem Soc 86, 301-307.
4. Gopala KAG, Gaurav R, Ajit SB, et al. (2010) Coconut oil: chemistry, production and its applications - a review. Indian Coconut J 73, 15-27.
5. Lopes MA & Larkins BA (1993) Endosperm origin, development and function. Plant cell 5, 1383-1399.
6. Hahn WJ (1997) Arecanae: the palms. In Tree of Life Web Project Website. http://tolweb.org/Arecanae/21337
7. Pearsall J (1999) Coconut Oxford Dictionary, 10th ed. Oxford: Clarendon Press.
8. Patrick JW & Offler CE (2001) Compartmentation of transport and transfer events in developing seeds. J Exp Bot 52, 551-564.
9. Janick J and Paull RE (editors) (2008) The Encyclopedia of Fruit & Nuts. Wallingford: CAB International.
10. Royal Botanic Gardens (2014) Cocos nucifera L. In World Checklist of Selected Plant Families [Royal Botanic Gardens, editor]. Kew: Royal Botanic Gardens.
11. Bach AC & Babayan VK (1982) Medium chain triglycerides: an update. Am J Clin Nutr 36, 950-962.
12. Chandrashekar P, Lokesh BR & Gopala KAG (2010) Hypolipidemic effect of blends of coconut oil with soybean oil or sunflower oil in experimental rats. Food Chem 123, 728-733.
13. Radenahmad N, Vongvatcharanon U, Withyachumnarnkul B, et al. (2006) Serum levels of 17β-estradiol in ovariectomized rats fed young-coconut-juice and its effect on wound healing. Songklanagarind J Sci Technol 28, 897-910.
14. Radenahmad N, Saleh F, Sawangjaroen K, et al. (2011) Young coconut juice, a potential therapeutic agent that could significantly reduce some pathologies associated with Alzheimer's disease: novel findings. Br J Nutr 105, 738-746.
15. Kumar PD (1997) The role of coconut and coconut oil in coronary heart disease in Kerala, south India. Trop Doct 27, 215-217.
16. Lindeberg S & Lundh B (1993) Apparent absence of stroke and ischaemic heart disease in a traditional Melanesian island: a clinical study in Kitava. J Intern Med 233, 269-275.
17. Villarino BJ, Dy LM & Lizada CC (2007) Descriptive sensory evaluation of virgin coconut oil and refined, bleached and deodorized coconut oil. LWT Food Sci Technol 40, 193-199.
18. Dauqan EMA, Sani HA, Abdullah A, et al. (2011) Fatty acids composition of four different vegetable oils (red palm olein, palm olein, corn oil and coconut oil) by gas chromatography. In 2nd International Conference on Chemistry and Chemical Engineering, 29-31 July 2011, Chengdu, China, pp. 31-34.
19. Nevin KG & Rajamohan T (2004) Beneficial effects of virgin coconut oil on lipid parameters and in vitro LDL oxidation. Clin Biochem 37, 830-835.
20. Scarmeas N, Stern Y, Tang MX, et al. (2006) Mediterranean diet and risk for Alzheimer's disease. Ann Neurol 59, 912-921.
21. Gu Y, Luchsinger JA, Stern Y, et al. (2010) Mediterranean diet, inflammatory and metabolic biomarkers, and risk of Alzheimer's disease. J Alzheimers Dis 22, 483-492.
22. Marina AM, Man YB, Nazimah SA, et al. (2009) Antioxidant capacity and phenolic acids of virgin coconut oil. Int J Food Sci Nutr 60, 114-123.
23. Müller H, Lindman AS, Blomfeldt A, et al. (2003) A diet rich in coconut oil reduces diurnal postprandial variations in circulating plasminogen activator antigen and fasting lipoprotein (a) compared with a diet rich in unsaturated fat in women. J Nutr 133, 3422-3427.
24. Traul KA, Driedger A, Ingle DL, et al. (2000) Review of the toxicologic properties of medium-chain triglycerides. Food Chem Toxicol 38, 79-98.
25. Warner K (2005) Effects on the flavor and oxidative stability of stripped soybean and sunflower oils with added pure tocopherols. J Agric Food Chem 53, 9906-9910.
26. Adam SK, Das S, Faizah O, et al. (2009) Fresh soy oil protects against vascular changes in an estrogen-deficient rat model: an electron microscopy study. Clinics 64, 1113-1119.
27. Ruppin DC & Middleton WRJ (1980) Clinical use of medium chain triglycerides. Drugs 20, 216-224.
28. Masson CJ, Plat J, Mensink RP, et al. (2010) Fatty acid- and cholesterol transporter protein expression along the human intestinal tract. PLoS ONE 5, 1-10.
29. Mishkin S, Stein L, Gatmaitan Z, et al. (1972) The binding of fatty acids to cytoplasmic proteins: binding to Z protein in liver and other tissues of the rat. Biochem Biophys Res Commun 47, 997-1003.
30. Holt PR (2007) Intestinal malabsorption in the elderly. Digest Dis 25, 144-150.
31. Mandelbaum-Schmid J (2004) Vitamin and mineral deficiencies harm one-third of the world's population. Bull World Health Organ 82, 230-231.
32. McCann JC & Ames BN (2011) Adaptive dysfunction of selenoproteins from the perspective of the triage theory: why modest selenium deficiency may increase risk of diseases of aging. FASEB J 25, 1793-1814.
33. Ockner RK, Manning JA, Poppenhausen RB, et al. (1972) A binding protein for fatty acids in cytosol of intestinal mucosa, liver, myocardium and other tissues. Science 177, 56-58.
34. Tholstrup T, Ehnholm C, Jauhiainen M, et al. (2004) Effects of medium-chain fatty acids and oleic acid on blood lipids, lipoproteins, glucose, insulin, and lipid transfer protein activities. Am J Clin Nutr 79, 564-569.
35. Tsuji H, Kasai M, Takeuchi H, et al. (2001) Dietary mediumchain triacylglycerols suppress accumulation of body fat in a double-blind, controlled trial in healthy men and women. J Nutr 131, 2853-2859.
36. Valdivieso V (1972) Absorption of medium-chain triglycerides in animals with pancreatic atrophy. Am J Dig Dis 17, 129-136.
37. Ippagunta S, Hadenfeldt TJ, Miner JL, et al. (2011) Dietary conjugated linoleic acid induces lipolysis in adipose tissue of coconut oil-fed mice but not soy oil-fed mice. Lipids 46, 821-830.
38. Agnew IE & Holdsworth CD (1971) The effect of fat on calcium absorption from a mixed meal in normal subjects, patients with malabsorptive disease, and patients with a partial gastrectomy. Gut 12, 973-980.
39. Tantibhedhyangkul P & Hashim SA (1978) Medium-chain triglyceride feeding in premature infants: effects on calcium and magnesium absorption. Pediatrics 61, 537-545.
40. Hamsi MA, Othman F, Das S, et al. (2014) Effect of consumption of fresh and heated virgin coconut oil on the blood pressure and inflammatory biomarkers: an experimental study in Sprague Dawley rats. Alexandria J Med 51, 53-63.
41. Leong XF, Najib MNM, Das S, et al. (2009) Intake of repeatedly heated palm oil causes elevation in blood pressure with impaired vasorelaxation in rats. Tohoku J Exp Med 219, 71-78.
42. Adam SK, Das S, Soelaiman IN, et al. (2008) Consumption of repeatedly heated soy oil increases the serum parameters related to atherosclerosis in ovariectomized rats. Tohoku J Exp Med 215, 219-226.
43. Paul NB & Concetta CD (2003) Transmembrane movement of exogenous long-chain fatty acids: proteins, enzymes, and vectorial esterification. Microbiol Mol Biol Rev 67, 454-472.
44. Hoppel C (2003) The role of carnitine in normal and altered fatty acid metabolism. AM J Kidney Dis 41, S4-S12.
45. Papamandjaris AA, Macdougall DE & Jones PJH (1998) Medium chain fatty acid metabolism and energy expenditure: obesity treatment implications. Life Sci 62, 1203-1221.
46. Dara LD, Jessica W, Hannah B, et al. (2010) Role of vascular risk factors and vascular dysfunction in Alzheimer's disease. Mt Sinai J Med 77, 82-102.
47. St-Onge MP & Jones PJ (2002) Physiological effects of medium-chain triglycerides: potential agents in the prevention of obesity. J Nutr 132, 329-332.
48. Assuncao ML, Ferreira HS, dos Santos AF, et al. (2009) Effects of dietary coconut oil on the biochemical and anthropometric profiles of women presenting abdominal obesity. Lipids 44, 593-601.
49. Xue C, Liu Y, Wang J, et al. (2009) Consumption of medium- and long-chain triacylglycerols decreases body fat and blood triglyceride in Chinese hypertriglyceridemic subjects. Eur J Clin Nutr 63, 879-886.
50. Flatt JP, Ravussin E & Acheson KJ (1985) Effects of dietary fat on postprandial substrate oxidation and on carbohydrate and fat balances. J Clin Invest 76, 1019-1024.
51. Hill JO, Peters JC, Yang D, et al. (1989) Thermogenesis in humans during overfeeding with medium-chain triglycerides. Metabolism 38, 641-648.
52. Scalfi L, Coltorti A & Contaldo F (1991) Postprandial thermogenesis in lean and obese subjects after meals supplemented with medium-chain and long-chain triglycerides. Am J Clin Nutr 53, 1130-1133.
53. Dulloo AG, Fathi M, Mensi N, et al. (1996) Twentyfour-hour energy expenditure and urinary catecholamines of humans consuming low-to-moderate amounts of medium-chain triglycerides: a dose-response study in human respiratory chamber. Eur J Clin Nutr 50, 152-158.
54. White MD, Papamandjaris AA & Jones PJH (1999) Enhanced postprandial energy expenditure with medium-chain fatty acid feeding is attenuated after 14 d in premenopausal women. Am J Clin Nutr 69, 883-889.
55. Noguchi O, Takeuchi H, Kubota F, et al. (2002) Larger diet-induced thermogenesis and less body fat accumulation in rats fed medium-chain triacylglycerols than in those fed long-chain triacylglycerols. J Nutr Sci Vitaminol 48, 524-529.
56. Kasai M, Nosaka N, Maki H, et al. (2002) Comparison of diet-induced thermogenesis of foods containing medium versus long-chain triacylglycerols. J Nutr Sci Vitaminol 48, 536-540.
57. Krotkiewski M (2001) Value of VLCD supplementation with medium chain triglycerides. Int J Obes Relat Metab Disord 25, 1393-1400.
58. Baba N, Bracco EF & Hashim SA (1982) Enhanced thermogenesis and diminished deposition of fat in response to overfeeding with diet containing medium chain triglyceride. Am J Clin Nutr 35, 678-682.
59. Poppitt SD, Strik CM, MacGibbon AKH, et al. (2010) Fatty acid chain length, postprandial satiety and food intake in lean men. Physiol Behav 101, 161-167.
60. Li JJ, Huang CJ & Xie D (2008) Anti-obesity effects of conjugated linoleic acid, docosahexaenoic acid, and eicosapentaenoic acid. Mol Nutr Food Res 52, 631-645.
61. Vemuri M, Kelley DS, Mackey BE, et al. (2007) Docosahexaenoic acid (DHA) but not eicosapentaenoic acid (EPA) prevents trans-10, cis-12 conjugated linoleic acid (CLA)-induced insulin resistance in mice. Metab Syndr Relat Disord 5, 315-322.
62. Hasselbalch SG, Knudsen GM, Jakobsen J, et al. (1994) Brain metabolism during short-term starvation in humans. J Cereb Blood Flow Metab 14, 125-131.
63. Page K, Williamson A, Yu N, et al. (2009) Medium-chain fatty acids improve cognitive function in intensively treated type 1 diabetic patients and support in vitro synaptic transmission during acute hypoglycemia. Diabetes 58, 1237-1244.
64. Morris AA (2005) Cerebral ketone body metabolism. J Inherit Metab Dis 28, 109-121.
65. Sumithran P, Prendergas LA, Delbridge E, et al. (2013) Ketosis and appetite-mediating nutrients and hormones after weight loss. Eur J Clin Nutr 67, 759-764.
66. Sato K, Yoshihiro K, Keon CA, et al. (1995) Insulin, ketone bodies, and mitochondrial energy transduction. FASEB J 9, 651-658.
67. Serra D, Casals N, Asins G, et al. (1993) Regulation of mitochondrial 3-hydroxy-3-methylglutaryl-coenzyme A synthase protein by starvation, fat feeding, and diabetes. Arch Biochem Biophys 307, 40-45.
68. Freeman JM & Kossoff EH (2010) Ketosis and the ketogenic diet, 2010: advances in treating epilepsy and other disorders. Adv Pediatr 57, 315-329.
69. Kashiwaya Y, Takeshima T, Mori N, et al. (2000) D-β-Hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. Proc Natl Acad Sci U S A 97, 5440-5444.
70. Rho JM, Anderson GD, Donevan SD, et al. (2002) Acetoacetate, acetone, and dibenzylamine (a contaminant in L-(+)-β-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo. Epilepsia 43, 358-361.
71. Likhodii SS, Serbanescu I, Cortez MA, et al. (2003) Anticonvulsant properties of acetone, a brain ketone elevated by the ketogenic diet. Ann Neurol 54, 219-226.
72. Tieu K, Perier C, Caspersen C, et al. (2003) D-β-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease. J Clin Invest 112, 892-901.
73. Freeman J, Veggiotti P, Lanzi G, et al. (2006) The ketogenic diet: from molecular mechanisms to clinical effects. Epilepsy Res 68, 145-180.
74. Imamura K, Takeshima T, Kashiwaya Y, et al. (2006) d-β-Hydroxybutyrate protects dopaminergic SH-SY5Y cells in a rotenone model of Parkinson's disease. J Neurosci Res 84, 1376-1384.
75. Puchowicz MA, Xu K, Sun X, et al. (2007) Diet-induced ketosis increases capillary density without altered blood flow in rat brain. Am J Physiol Endocrinol Metab 292, E1607-E1615.
76. Kwiterovich PO Jr, Vining EP, Pyzik P, et al. (2003) Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children. JAMA 290, 912-920.
77. Patel A, Pyzik PL, Turner Z, et al. (2010) Long-term outcomes of children treated with the ketogenic diet in the past. Epilepsia 51, 1277-1282.
78. Klag MJ, Ford DE, Mead LA, et al. (1993) Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med 328, 313-318.
79. Alexander L, Rogovik MD & Ran DG (2010) Ketogenic diet for treatment of epilepsy. Can Fam Physician 56, 540-542.
80. Liu YM, Williams S, Basualdo-Hammond C, et al. (2003) A prospective study: growth and nutritional status of children treated with the ketogenic diet. J Am Diet Assoc 103, 707-712.
81. Liu YM (2008) Medium-chain triglyceride (MCT) ketogenic therapy. Epilepsia 49, 33-36.
82. Steen E, Terry BM, Rivera EJ, et al. (2005) Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease - is this type 3 diabetes? J Alzheimers Dis 7, 63-80.
83. Mosconi L (2005) Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging 32, 486-510.
84. Barañano KW & Hartman AL (2008) The ketogenic diet: uses in epilepsy and other neurologic illnesses. Curr Treat Options Neurol 10, 410-419.
85. Reger MA, Henderson ST, Hale C, et al. (2004) Effects of β-hydroxybutyrate on cognition in memory-impaired adults. Neurobiol Aging 25, 311-314.
86. Newport MT (2010) Caregiver reports following dietary intervention with medium chain fatty acids in 60 persons with dementia. In International Symposium of Dietary Interventions for Epilepsy and other Neurological Diseases, October 2010, Edinburgh, Scotland.
87. Henderson ST, Vogel JL, Barr LJ, et al. (2009) Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial. Nutr Metab (Lond) 6, 31.
88. Castellani RJ, Lee HG, Zhu X, et al. (2008) Alzheimer disease pathology as a host response. J Neuropathol Exp Neurol 67, 523-531.
89. 18F-fluorodeoxyglucose: a dual-tracer PET imaging study in rats. Nutr Neurosci 14, 51-58.
90. Roy M, Nugent S, Tremblay-Mercier J, et al. (2012) The ketogenic diet increases brain glucose and ketone uptake in aged rats: a dual tracer PET and volumetric MRI study. Brain Res 1488, 14-23.
91. Nafar F & Mearow KM (2014) Coconut oil attenuates the effects of amyloid-β on cortical neurons in vitro. J Alzheimers Dis 39, 233-237.
92. Van Der Auwera I, Wera S, Van Leuven F, et al. (2005) A ketogenic diet reduces amyloid β 40 and 42 in a mouse model of Alzheimer's disease. Nutr Metab 2, 28.
93. Studzinski CM, MacKay WA, Beckett TL, et al. (2008) Induction of ketosis may improve mitochondrial function and decrease steady-state amyloid-β precursor protein (APP) levels in the aged dog. Brain Res Bull 1226, 209-217.
94. Kashiwaya Y, Bergman C, Lee JH, et al. (2013) A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease. Neurobiol Aging 34, 1530-1539.
95. Beckett TL, Studzinski CM, Keller JN, et al. (2013) A ketogenic diet improves motor performance but does not affect β-amyloid levels in a mouse model of Alzheimer's disease. Brain Res 1505, 61-67.
96. Dashti HM, Mathew TC, Khadada M, et al. (2007) Beneficial effects of ketogenic diet in obese diabetic subjects. Mol Cell Biochem 302, 249-256.
97. Westman EC, Yancy WS Jr, Mavropoulos JC, et al. (2008) The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus. Nutr Metab (Lond) 5, 36.
98. Paoli A, Bianco A, Grimaldi KA, et al. (2013) Long term successful weight loss with a combination biphasic ketogenic Mediterranean diet and Mediterranean diet maintenance protocol. Nutrients 5, 5205-5217.
99. Morris MC, Evans DA, Bienias JL, et al. (2003) Dietary fats and the risk of incident Alzheimer disease. Arch Neurol 60, 194-200.
100. Freeman JM, Vining EPG, Pillas DJ, et al. (1998) The efficacy of the ketogenic diet - 1998: a prospective evaluation of intervention in 150 children. Pediatrics 102, 1358-1363.
101. Hall ED, Andrus PK & Yonkers PA (1993) Brain hydroxyl radical generation in acute experimental head injury. J Neurochem 60, 588-594.
102. Kielb S, Koo HP, Bloom DA, et al. (2000) Nephrolithiasis associated with the ketogenic diet. J Urol 164, 464-466.
103. Hiraide A, Katayama M, Sugimoto H, et al. (1991) Effect of 3-hydroxybutyrate on posttraumatic metabolism in man. Surgery 109, 176-181.
104. Hasselbalch SG, Madsen PL, Hageman LP, et al. (1996) Changes in cerebral blood flow and carbohydrate metabolism during acute hyperketonemia. Am J Physiol 270, E746-E751.
105. Westerterp-Plantenga MS, Nieuwenhuizen A, Tome D, et al. (2009) Dietary protein, weight loss, and weight maintenance. Ann Rev Nutr 29, 21-41.
106. Skov AR, Haulrik N, Toubro S, et al. (2002) Effect of protein intake on bone mineralization during weight loss: a 6-month trial. Obes Res 10, 432-438.
107. Poplawski MM, Mastaitis JW, Isoda F, et al. (2011) Reversal of diabetic nephropathy by a ketogenic diet. PLoS ONE 6, e18604.
108. Cahill GF Jr (2006) Fuel metabolism in starvation. Ann Rev Nutr 26, 1-22.
109. Kim DS, Park SY & Kim JY (2001) Curcuminoids from Curcuma longa L. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from βA (1-42) insult. Neurosci Lett 303, 57-61.
110. Park YS & Kim DS (2002) Discovery of natural products from Curcuma longa that protect cells from β-amyloid insult: a drug discovery effort against Alzheimer's disease. J Nat Prod 65, 1227-1231.
111. Tepe B, Sokmen M, Sokmen A, et al. (2005) Antimicrobial and antioxidative activity of the essential oil and various extracts of Cyclotrichium origanifolium (Labill.) Manden. & Scheng. J Food Eng 69, 335-342.
112. Necula M, Kayed R, Milton S, et al. (2007) Small molecule inhibitors of aggregation indicate that amyloid β oligomerization and fibrillization pathways are independent and distinct. J Biol Chem 282, 10311-10324.
113. Shah R (2013) The role of nutrition and diet in Alzheimer disease: a systematic review. J Am Med Dir Assoc 14, 398-402.
114. Hirohata M, Hasegawa K, Tsutsumi-Yasuhara S, et al. (2007) The anti-amyloidogenic effect is exerted against Alzheimer's β-amyloid fibrils in vitro by preferential and reversible binding of flavonoids to the amyloid fibril structure. Biochemistry 46, 1888-1889.
115. 1H-NMR spectroscopy. Eur J Biochem 219, 923-935.
116. Richard T, Verge S, Berke B, et al. (2001) NMR and simulated annealing investigations of bradykinin in presence of polyphenols. J Biomol Struct Dyn 18, 627-637.
117. Savaskan E, Olivieri G, Meier F, et al. (2003) Red wine ingredient resveratrol protects from β-amyloid neurotoxicity. Gerontology 49, 380-383.
118. Bastianetto S & Quirion R (2004) Natural antioxidants and neurodegenerative diseases. Front Biosci 9, 3447-3452.
119. Krebs MRH, Bromley EHC & Donald AMT (2005) The binding of thioflavin-T to amyloid fibrils: localization and implications. J Struct Biol 149, 30-37.
120. Ono K, Hasegawa K, Naiki H, et al. (2004) Curcumin has potent anti-amyloidogenic effects for Alzheimer's β-amyloid fibrils in vitro. J Neurosci Res 75, 742-750.
121. Porat Y, Abramowitz A & Gazit E (2006) Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism. Chem Biol Drug Des 67, 27-37.
122. Wang J, Ho L, Zhao W, et al. (2008) Grape-derived polyphenolics prevent Aβ oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease. J Neurosci 28, 6388-6392.
123. Singh M, Arseneault M, Sanderson T, et al. (2008) Challenges for research on polyphenols from foods in Alzheimer's disease: bioavailability, metabolism, and cellular and molecular mechanisms. J Agr Food Chem 56, 4855-4873.
124. Ono K, Hirohata M & Yamada M (2005) Ferulic acid destabilizes preformed β-amyloid fibrils in vitro. Biochem Biophys Res Commun 336, 444-449.
125. Zhao ZH & Moghadasian MH (2008) Chemistry, natural sources, dietary intake and pharmacokinetic properties of ferulic acid. Food Chem 109, 691-702.
126. Ono K, Condron MM, Ho L, et al. (2008) Effects of grape seed-derived polyphenols on amyloid β-protein self-assembly and cytotoxicity. J Biol Chem 283, 32176-32187.
127. Ji-Jing Y, Jun-Sub J, Taek-Keun KM, et al. (2013) Protective effects of ferulic acid in amyloid precursor protein plus presenilin-1 transgenic mouse model of Alzheimer disease. Biol Pharm Bull 36, 140-143.
128. Seema J & Jayakumar R (2012) Effect of phenolic compounds against Aβ aggregation and Aβ-induced toxicity in transgenic C. elegans. Neurochem Res 37, 40-48.
129. McLaurin J, Kierstead ME, Brown ME, et al. (2006) Cyclohexanehexol inhibitors of Aβ aggregation prevent and reverse Alzheimer. Nat Med 12, 801-808.
130. Ji-Jing Y, Jae-Young C, Hee-Sung K, et al. (2001) Protection against β-amyloid peptide toxicity in vivo with long-term administration of ferulic acid. Br J Pharmacol 133, 89-96.
131. Konishi Y, Hitomi Y & Yoshioka E (2004) Intestinal absorption of p-coumaric and gallic acids in rats after oral administration. J Agric Food Chem 52, 2527-2532.
132. Martins IJ, Hone E, Foster JK, et al. (2006) Apolipoprotein E, cholesterol metabolism, diabetes and the convergence of risk factors for Alzheimer's disease and cardiovascular disease. Mol Psychiatr 11, 721-736.
133. Martins IJ, Berger T, Sharman MJ, et al. (2009) Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease. J Neurochem 111, 1275-1308.
134. Ali AT, Ferris WF, Naran NH, et al. (2011) Insulin resistance in the control of body fat distribution: a new hypothesis. Horm Metab Res 43, 77-80.
135. Fernández-Real JM, López-Bermejo A, Vendrell J, et al. (2006) Burden of infection and insulin resistance in healthy middle-aged men. Diabetes Care 29, 1058-1064.
136. Behl C, Davis JB, Klier FG, et al. (1994) Amyloid β peptide induces necrosis rather than apoptosis. Brain Res Bull 645, 253-264.
137. Sircar S & Kansra U (1998) Choice of cooking oils - myths and realities. J Indian Med Assoc 96, 304-307.
138. Kochikuzhyil BM, Devi K & Fattepur SR (2010) Effect of saturated fatty acid-rich dietary vegetable oils on lipid profile, antioxidant enzymes and glucose tolerance in diabetic rats. Indian J Pharmacol 42, 142-145.
139. Sun H, Jiang T, Wang S, et al. (2013) The effect of LXRα, ChREBP and Elovl6 in liver and white adipose tissue on medium- and long-chain fatty acid diet-induced insulin resistance. Diabetes Res Clin Pract 102, 183-192.
140. Montgomery MK, Osborne B, Brown SH, et al. (2013) Contrasting metabolic effects of medium- versus long-chain fatty acids in skeletal muscle. J Lipid Res 54, 3322-3333.
141. Liberato MV, Nascimento AS, Ayers SD, et al. (2012) Medium chain fatty acids are selective peroxisome proliferator activated receptor (PPAR) γ activators and pan-PPAR partial agonists. PLOS ONE 7, e36297.
142. Marçal AC, Camporez JP, Lima-Salgado TM, et al. (2013) Changes in food intake, metabolic parameters and insulin resistance are induced by an isoenergetic, medium-chain fatty acid diet and are associated with modifications in insulin signalling in isolated rat pancreatic islets. Br J Nutr 28, 2154-2165.
143. Sykes G & Margaret CH (1954) Phenol as the preservative in insulin injections. J Pharm Pharmacol 6, 552-557.
144. Nomura E, Kashiwada A, Hosoda A, et al. (2003) Synthesis of amide compounds of ferulic acid, and their stimulatory effects on insulin secretion in vitro. Bioorg Med Chem 11, 3807-3813.
145. Cox C, Sutherland W, Mann J, et al. (1998) Effects of dietary coconut oil, butter and safflower oil on plasma lipids, lipoproteins and lathosterol levels. Eur J Clin Nutr 52, 650-654.
146. Iwamoto T, Watanabe D, Umahara T, et al. (2004) Dual inverse effects of lipoprotein(a) on the dementia process in Japanese late-onset Alzheimer's disease. Psychogeriatrics 4, 64-71.
147. Matsuzaki T, Sasaki K, Hata J, et al. (2011) Association of Alzheimer disease pathology with abnormal lipid metabolism: the Hisayama Study. Neurology 77, 1068-1075.
148. Eliasson MC, Jansson JH, Lindahl B, et al. (2003) High levels of tissue plasminogen activator (tPA) antigen precede the development of type 2 diabetes in a longitudinal population study. The Northern Sweden MONICA Study. Cardiovasc Diabetol 22, 19.
149. Feranil AB, Duazo PL, Kuzawa CW, et al. (2011) Coconut oil is associated with a beneficial lipid profile in pre-menopausal women in the Philippines. Asia Pac J Clin Nutr 20, 190-195.
150. Siri-Tarino PW, Sun Q, Hu FB, et al. (2010) Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr 91, 535-546.
151. Tsai Y-H, Park S, Kovacic J, et al. (1999) Mechanisms mediating lipoprotein responses to diets with medium-chain triglyceride and lauric acid. Lipids 34, 895-905.
152. Cater NB, Heller HJ & Denke MA (1997) Comparison of the effects of medium-chain triacylglycerols, palm oil, and high oleic acid sunflower oil on plasma triacylglycerol fatty acids and lipid and lipoprotein concentrations in humans. Am J Clin Nutr 65, 41-45.
153. Ganji V & Kies CV (1996) Psyllium husk fiber supplementation to the diets rich in soybean or coconut oil: hypocholesterolemic effect in healthy humans. Int J Food Sci Nutr 47, 103-110.
154. Hayatullina Z, Norliza M, Norazlina M, et al. (2012) Virgin coconut oil supplementation prevents bone loss in osteoporosis rat model. Evid Based Complement Alternat Med 2012, 237236.
155. Isaacs CE & Thormar H (1990) Human Milk Lipids Inactivated Enveloped Viruses, Breastfeeding, Nutrition, Infection and Infant Growth in Developed and Emerging Countries. St John's Newfoundland: Arts Biomedical.
156. Seneviratnea KN, HapuarachchIa CD & Ekanayake S (2009) Comparison of the phenolic-dependent antioxidant properties of coconut oil extracted under cold and hot conditions. Food Chem 114, 1444-1449.
157. Mahadevappa S, Arunchand R & Farhath K (2011) Antidiabetic effects of cold and hot extracted virgin coconut oil. J Diabetes Mellit 1, 118-123.
158. Zlokovic BV (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57, 178-201.
159. Pardridge WM (2005) The blood-brain barrier and neurotherapeutics. NeuroRx 2, 1-2.
160. Laffel L (1999) Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev 15, 412-426.
161. Wlaź P, Socała K, Nieoczym D, et al. (2012) Anticonvulsant profile of caprylic acid, a main constituent of the mediumchain triglyceride (MCT) ketogenic diet, in mice. Neuropharmacology 62, 1882-1889.
162. Adams W & Bralt DE (1992) Young coconut water for home rehydration in children with mild gastroenteritis. Trop Geogr Med 44, 149-153.
163. Letham DS (1974) Regulators of cell division in plant tissues. XX. The cytokinins of coconut milk. Physiol Plant 32, 66-70.
164. Huan L, Takamura T & Tanaka M (2004) Callus formation and plant regeneration from callus through somatic embryo structures in Cymbidium orchid. Plant Sci 166, 1443-1449.
165. Choi SJ, Jeong CH, Choi SG, et al. (2009) Zeatin prevents amyloid β-induced neurotoxicity and scopolamine-induced cognitive deficits. J Med Food 12, 271-277.
166. Heo HJ, Hong SC, Cho HY, et al. (2002) Inhibitory effect of zeatin, isolated from Fatoua villosa, on acetylcholinesterase activity from PC12 cells. Mol Cells 13, 113-117.
167. Mirjana BČ, Danijela ZK & Tamara DL (2013) Acetylcholinesterase inhibitors: pharmacology and toxicology. Curr Neuropharmacol 11, 315-335.
168. Sandhya VG & Rajamohan T (2006) Beneficial effects of coconut water feeding on lipid metabolism in cholesterolfed rats. J Med Food 9, 400-407.
169. Alleyne T, Roache S, Thomas C, et al. (2005) The control of hypertension by use of coconut water and mauby: two tropical food drinks. West Indian Med J 54, 3-8.
170. Chukwunonso ECCE, Obioma ON & Ifeoma II (2010) Consumption of coconut milk did not increase cardiovascular disease risk in mice. Int J Curr Res 6, 063-064.
171. Ekanayaka RA, Ekanayaka NK, Perera B, et al. (2013) Impact of a traditional dietary supplement with coconut milk and soya milk on the lipid profile in normal free living subjects. J Nutr Metab 2013, 481068.
172. Trinidad PT, Anacleta SL, Aida CM, et al. (2004) The cholesterol-lowering effect of coconut flakes in humans with moderately raised serum cholesterol. J Medi Food 7, 136-140.
173. Ng SP, Tan CP, Lai OM, et al. (2010) Extraction and characterization of dietary fiber from coconut residue. J Food Agric Environ 8, 172-177.
174. Salil G, Nevin KG & Rajamohan T (2011) Arginine rich coconut kernel protein modulates diabetes in alloxan treated rats. Chem Biol Interact 189, 107-111.
175. Nwangwa EK & Chukwuemeka PA (2011) Regenerative effects of coconut water and coconut milk on the pancreatic β-cells and cyto architecture in alloxan induced diabetic Wistar Albino rat. Am J Trop Med Public Health 1, 137-146.
176. Hoang HH, Padgham SV & Meininger CJ (2013) L-Arginine, tetrahydrobiopterin, nitric oxide and diabetes. Curr Opin Clin Nutr Metab Care 16, 76-82.